Lexaria Bioscience Corp.

NASDAQ: LEXX
Nasdaq Stock Market
Healthcare Biotechnology
Global Rank
#43023
Country Rank
#1649
Market Cap
9.06 M
Price
5.48
Change (%)
2.49%
Volume
72,231

Lexaria Bioscience Corp.'s latest marketcap:

9.06 M

As of 08/06/2026, Lexaria Bioscience Corp.'s market capitalization has reached $9.06 M. According to our data, Lexaria Bioscience Corp. is the 43023th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 9.06 M
Revenue (ttm) 194,000
Net Income (ttm) -7,732,026
Shares Out 1.65 M
EPS (ttm) -5.14
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 07/13/2026
Market Cap Chart
Data Updated: 08/06/2026

Lexaria Bioscience Corp.'s yearly market capitalization.

Lexaria Bioscience Corp. has seen its market value drop from $18.9 M to $9.06 M since 2007, representing a total decrease of 52.09% and an annual compound decline rate (CAGR) of 3.88%.
Date Market Cap($) Change (%) Global Rank
08/06/2026 $9.06 M 9.64% 43023
12/31/2025 $13.7 M -62.67% 35574
12/31/2024 $36.7 M 186.72% 30122
12/29/2023 $12.8 M -12.33% 36004
12/30/2022 $14.6 M -36.8% 34251
12/31/2021 $23.1 M 2.67% 31994
12/31/2020 $22.5 M -24.75% 28957
12/31/2019 $29.9 M -58.3% 24581
12/31/2018 $71.7 M -38.87% 19036
12/29/2017 $117.3 M 624.07% 17168

Company Profile

Lexaria Bioscience Corp. was founded in 2004 in Canada. on the Nasdaq Stock Market. With 7 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.

Frequently Asked Questions

  • What is Lexaria Bioscience Corp.'s (LEXX) current market cap?
    As of 08/06/2026, Lexaria Bioscience Corp. (including the parent company, if applicable) has an estimated market capitalization of $9.06 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Lexaria Bioscience Corp. global market capitalization ranking is approximately 43023 as of 08/06/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.